【中国新闻网】破解临床骨缺损修复难题 中国团队历时15年研发材料获准上市

Core Viewpoint - The "magnesium-containing biodegradable polymer bone repair material" developed by the Shenzhen Institute of Advanced Technology has received approval for clinical use, addressing the challenge of clinical bone defect repair after 15 years of research [1][2]. Group 1: Product Development and Innovation - The innovative "magnesium-containing biodegradable polymer bone repair material" fills a gap in the industry and is developed by a team from the Shenzhen Institute of Advanced Technology, in collaboration with Shenzhen Zhongke Jingcheng Medical Technology Co., Ltd. [2] - The material was created using a low-temperature 3D printing method, overcoming multiple technical challenges in orthopedic device manufacturing, achieving precise shaping and a biomimetic structure with suitable strength [2]. - The material exhibits mechanical strength comparable to human cancellous bone, providing stable support during surgical procedures and avoiding disintegration or fragmentation [2]. Group 2: Clinical Trials and Efficacy - The clinical trials involved 176 patients with bone defects across eight major research hospitals in Beijing and Shanghai, showing a bone fusion rate of over 98% at 24 weeks without any rejection reactions [3]. - The material can be shaped during surgery, allowing it to adapt to complex bone defect shapes, which is a significant advantage over traditional bone repair methods [3]. Group 3: Future Directions and Market Potential - The research team plans to expand the clinical applications of the "magnesium-containing biodegradable polymer bone repair material" to improve precision and efficiency in bone repair, addressing complex bone defects and challenging bone diseases [5]. - The material is positioned as a safe and effective solution for bone repair, significantly enhancing the success rate of bone repair procedures and improving patient recovery and quality of life [5].